The pledge by multiple coronavirus vaccine developers to follow high development standards may alleviate as much pressure on the US Food and Drug Administration as it does on the individual companies pushing to make their products available.
Nine vaccine sponsor CEOs announced a non-binding commitment 8 September (see box) to always make the safety and well-being of...







